Visnes Torkild, Akbari Mansour, Hagen Lars, Slupphaug Geir, Krokan Hans E
Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Erling Skjalgssons gate 1, Trondheim, Norway.
DNA Repair (Amst). 2008 Nov 1;7(11):1869-81. doi: 10.1016/j.dnarep.2008.07.012. Epub 2008 Sep 4.
Uracil in DNA is repaired by base excision repair (BER) initiated by a DNA glycosylase, followed by strand incision, trimming of ends, gap filling and ligation. Uracil in DNA comes in two distinct forms; U:A pairs, typically resulting from replication errors, and mutagenic U:G mismatches, arising from cytosine deamination. To identify proteins critical to the rate of repair of these lesions, we quantified overall repair of U:A pairs, U:G mismatches and repair intermediates (abasic sites and nicked abasic sites) in vitro. For this purpose we used circular DNA substrates and nuclear extracts of eight human cell lines with wide variation in the content of BER proteins. We identified the initiating uracil-DNA glycosylase UNG2 as the major overall rate-limiting factor. UNG2 is apparently the sole glycosylase initiating BER of U:A pairs and generally initiated repair of almost 90% of the U:G mismatches. Surprisingly, TDG contributed at least as much as single-strand selective monofunctional uracil-DNA glycosylase 1 (SMUG1) to BER of U:G mismatches. Furthermore, in a cell line that expressed unusually high amounts of TDG, this glycosylase contributed to initiation of as much as approximately 30% of U:G repair. Repair of U:G mismatches was generally faster than that of U:A pairs, which agrees with the known substrate preference of UNG-type glycosylases. Unexpectedly, repair of abasic sites opposite G was also generally faster than when opposite A, and this could not be explained by the properties of the purified APE1 protein. It may rather reflect differences in substrate recognition or repair by different complex(es). Lig III is apparently a minor rate-regulator for U:G repair. APE1, Pol beta, Pol delta, PCNA, XRCC1 and Lig I did not seem to be rate-limiting for overall repair of any of the substrates. These results identify damaged base removal as the major rate-limiting step in BER of uracil in human cells.
DNA中的尿嘧啶通过碱基切除修复(BER)进行修复,该过程由DNA糖基化酶启动,随后进行链切割、末端修剪、缺口填充和连接。DNA中的尿嘧啶有两种不同形式:U:A配对,通常由复制错误导致;以及诱变的U:G错配,由胞嘧啶脱氨产生。为了鉴定对这些损伤修复速率至关重要的蛋白质,我们在体外定量了U:A配对、U:G错配以及修复中间体(无碱基位点和带切口的无碱基位点)的整体修复情况。为此,我们使用了环状DNA底物以及八种人细胞系的核提取物,这些细胞系中BER蛋白的含量差异很大。我们鉴定出起始尿嘧啶-DNA糖基化酶UNG2是主要的整体限速因子。UNG2显然是启动U:A配对BER的唯一糖基化酶,并且通常启动几乎90%的U:G错配的修复。令人惊讶的是,TDG对U:G错配BER的贡献至少与单链选择性单功能尿嘧啶-DNA糖基化酶1(SMUG1)一样大。此外,在一个表达异常大量TDG的细胞系中,这种糖基化酶促成了约30%的U:G修复的起始。U:G错配的修复通常比U:A配对的修复更快,这与UNG型糖基化酶已知的底物偏好一致。出乎意料的是,与G相对的无碱基位点的修复通常也比与A相对时更快,这无法用纯化的APE1蛋白的特性来解释。这可能更反映了不同复合物在底物识别或修复方面的差异。Lig III显然是U:G修复的次要速率调节因子。APE1、Pol β、Pol δ、PCNA、XRCC1和Lig I似乎对任何底物的整体修复都不是限速因素。这些结果表明,受损碱基的去除是人类细胞中尿嘧啶BER的主要限速步骤。